Table 3.

Effect of Adherence on Medicaid Expenditures per Patient and Aggregated Across 14-State Southern Region

Adherence Model (high adherence = ICS-Rx/ total asthma medication ≥50%)	Expected Annual Cost per Patient: Mean (95% CI)	Difference (projected annual cost savings per patient)	Annual Projected Aggregate Medicaid Savings Across 14 Southern States (n = 409,106): Mean (95% CI)
Actual adherence = 33.35%	$4969.31 ($4633.53–$5304.80)	—	—
40%	$4874.32 ($4538.12–$5210.32)	$94.99 ($94.48–$95.41)	$8,198,777 ($8,154,758–$8,235,028)
50%	$4731.47 ($4394.64–$5068.25)	$237.84 ($236.55–$238.99)	$20,528,446 ($20,417,104–$20,627,705)
60%	$4588.63 ($4251.17–$4926.18)	$380.68 ($378.62–$382.36)	$32,857,252 ($32,679,449–$33,002,256)
70%	$4445.78 ($4107.69–$4784.12)	$523.53 ($520.68, $525.84)	$45,186,921 ($44,940,932–$45,386,302)
80%	$4302.94 ($3964.22–$4642.05)	$666.37 ($662.75–$669.31)	$57,515,727 ($57,203,278–$57,769,485)
90%	$4160.10 ($3820.74–$4499.98)	$809.21 ($804.82–$812.79)	$69,844,534 ($69,465,624–$70,153,530)
100%	$4017.25 ($3677.26–$4357.91)	$952.06 ($946.89–$956.27)	$82,174,203 ($81,727,970–$82,537,576)

ICS-Rx indicates inhaled corticosteroid.